both exenatide and metformin had similar effects on microvascular endothelial function measured by the reactive hyperemic index (RHI), as well as levels of inflammatory and oxidative stress markers including C-reactive protein (CRP), oxidized LDL (oxLDL), and vascular cell adhesion molecule-1 (VCAM-1) levels [63]
In FDAs RUO/IUO IVD guidance, RUO labeling is discussed as a way to prevent research products in that category from being represented for clinical diagnostic use [5]
Growth hormone 101: definition, where it comes from, and the challenges of measuring it [28:45]
This journey with GLP-1s has been eye-opening for me, not just for the physical changes, but for the deeper understanding of how interconnected our brains and bodies areand how that knowledge could lead to breakthroughs in addiction treatment
For oral peptide supplements, the answer is: there is no meaningful evidence that they produce clinically significant fat loss in healthy adults at the doses typically used in commercial products
Cognitive functioning in chronic fatigue syndrome: a meta-analysis